Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check13 days agoChange DetectedA note clarifying that PubMed-listed publications are automatically populated from PubMed and may not all relate to the study was added, replacing the previous wording. The revision version label was updated from v3.2.0 to v3.3.1, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedDeleted boilerplate notice about a lapse in government funding and NIH operating status; study details and core content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and study details remain the same, with only minor formatting differences.SummaryDifference0.4%

- Check63 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping only the version bump.SummaryDifference0.2%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.